P
Procept Biorobotics Corp
NASDAQ:PRCT
Procept Biorobotics Corp
NASDAQ:PRCT
Price:
27.36
USD
-2.25%
Market Closed
Market Cap:
$1.5B
Balance Sheet
Balance Sheet Decomposition
Procept Biorobotics Corp
Procept Biorobotics Corp
Balance Sheet Decomposition is not available for
Procept Biorobotics Corp
Procept Biorobotics Corp
Balance Sheet
Procept Biorobotics Corp
Procept Biorobotics Corp
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
42
|
100
|
304
|
222
|
251
|
334
|
287
|
|
| Cash |
0
|
0
|
14
|
9
|
0
|
11
|
11
|
|
| Cash Equivalents |
42
|
100
|
291
|
213
|
251
|
323
|
275
|
|
| Total Receivables |
1
|
2
|
5
|
15
|
48
|
83
|
84
|
|
| Accounts Receivables |
1
|
2
|
5
|
15
|
48
|
83
|
84
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
7
|
8
|
14
|
29
|
40
|
56
|
71
|
|
| Other Current Assets |
1
|
1
|
3
|
7
|
5
|
8
|
10
|
|
| Total Current Assets |
51
|
110
|
326
|
273
|
351
|
482
|
450
|
|
| PP&E Net |
8
|
13
|
8
|
32
|
49
|
46
|
48
|
|
| PP&E Gross |
8
|
13
|
8
|
32
|
49
|
46
|
48
|
|
| Accumulated Depreciation |
2
|
5
|
7
|
9
|
4
|
8
|
13
|
|
| Intangible Assets |
2
|
2
|
2
|
2
|
1
|
1
|
1
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
3
|
4
|
6
|
9
|
|
| Total Assets |
62
N/A
|
126
+103%
|
337
+167%
|
309
-8%
|
405
+31%
|
534
+32%
|
508
-5%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
1
|
2
|
9
|
13
|
10
|
17
|
|
| Accrued Liabilities |
3
|
8
|
11
|
21
|
22
|
28
|
30
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
5
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
2
|
1
|
3
|
5
|
10
|
15
|
18
|
|
| Total Current Liabilities |
7
|
15
|
16
|
35
|
46
|
53
|
66
|
|
| Long-Term Debt |
23
|
44
|
50
|
51
|
51
|
51
|
52
|
|
| Other Liabilities |
3
|
6
|
4
|
26
|
27
|
27
|
25
|
|
| Total Liabilities |
33
N/A
|
65
+98%
|
70
+8%
|
112
+61%
|
124
+10%
|
132
+6%
|
142
+8%
|
|
| Equity | ||||||||
| Common Stock |
173
|
244
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
149
|
202
|
262
|
349
|
455
|
546
|
642
|
|
| Additional Paid In Capital |
5
|
19
|
529
|
546
|
735
|
948
|
1 007
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
29
N/A
|
61
+109%
|
267
+338%
|
197
-26%
|
281
+42%
|
402
+43%
|
366
-9%
|
|
| Total Liabilities & Equity |
62
N/A
|
126
+103%
|
337
+167%
|
309
-8%
|
405
+31%
|
534
+32%
|
508
-5%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
42
|
42
|
44
|
45
|
51
|
55
|
56
|
|
Switch to:
Switch to:
See Also
Discover More
